Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dehydrogenase enzyme family" is not a specific molecular target but a broad and heterogeneous class that includes many different enzyme families such as aldehyde dehydrogenases (ALDH), alcohol dehydrogenases (ADH), lactate dehydrogenases, and others. Each of these is itself a family (or superfamily) with specific subclasses and isoforms, each of which can be considered an individual target. For example, ALDHs are responsible for the oxidation of aldehydes to carboxylic acids and include at least 19 human genes divided into subclasses, each with distinct physiological and pathophysiological roles[1][2][3][4]. Similarly, the ADH family encompasses enzymes responsible for interconversion between alcohols and aldehydes, itself divided into several superfamilies and gene classes depending on sequence and functional similarity[6]. Thus, "dehydrogenase enzyme family" as a general label is too broad for precise targeting or structured use: it lacks the specificity required to map to a single gene, protein, or druggable target. Each distinct enzyme (e.g., Aldehyde dehydrogenase 2, Alcohol dehydrogenase 1B) would require its own structured entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dehydrogenase enzyme family.